$BGMD Headlines BG Medicine Inc. falls 10% in pr
Post# of 89346
Posted On: 01/06/2014 1:42:51 PM
$BGMD Headlines
BG Medicine Inc. falls 10% in premarket 7:58 a.m. Jan. 25, 2013 - Steve Gelsi
BG Medicine up 11% in premarket 7:57 a.m. Jan. 3, 2013 - Steve Gelsi
BG Medicine up by 16% in premarket 8:49 a.m. Dec. 14, 2012 - Steve Gelsi
BG Medicine rises 9% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi
BG Medicine names BioMerieux exec as CEO 9:12 a.m. Jan. 9, 2012 - Steve Gelsi
BG Medicine names Eric Bouvier as CEO 8:38 a.m. Jan. 9, 2012 - Steve Gelsi
IPO scorecard: Pacira, Epocrates up in aftermarket 1:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 1:31 p.m. April 26, 2011 - MarketWatch.com
HWAY and SulAmerica Join Forces, Shares Fall - Analyst Blog 6:30 p.m. Dec. 9, 2013 - Zacks.com
Omnicare Raises Dividend, Approves Share Repurchase - Analyst Blog 3:00 p.m. Dec. 9, 2013 - Zacks.com
Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape 9:25 a.m. Nov. 18, 2013 - Zacks.com
BG Medicine's CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:03 p.m. Nov. 6, 2013 - Seeking Alpha
Healthways Partnership Expands But Stock Down - Analyst Blog 1:50 p.m. Oct. 7, 2013 - Zacks.com
CareFirst Invests in Healthways Partnership - Analyst Blog 1:50 p.m. Oct. 4, 2013 - Zacks.com
NextGxDx and athenahealth Join Forces - Analyst Blog 5:10 p.m. Oct. 1, 2013 - Zacks.com
BG Medicine Says Prelim. Decision by CMS on Galectin-3 National limitation $30.24 6:33 a.m. Sept. 30, 2013 - benzinga.com
BG Medicine - Just Be Patient 3:02 a.m. Aug. 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 3:10 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
BG Medicine's CEO Discusses Q2 2013 Results - Earnings Call Transcript 12:35 p.m. Aug. 8, 2013 - Seeking Alpha
Don’t Take a Shot on That Small-Cap Biotech 5:48 a.m. June 11, 2013 - InvestorPlace.com
Emerging Biomarker Companies Redux: Positioned For Growth 2:31 p.m. May 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 3:18 p.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
BG Medicine's CEO Discusses Q1 2013 Results - Earnings Call Transcript 1:10 p.m. May 9, 2013 - Seeking Alpha
Zacks #1 Rank Additions for Thursday - Tale of the Tape 7:44 a.m. May 2, 2013 - Zacks.com
Zacks Rank #1 Addition for Friday - Tale of the Tape 7:44 a.m. April 19, 2013 - Zacks.com
Abbott Launches Automated Solution - Analyst Blog 5:00 p.m. April 18, 2013 - Zacks.com
Abbott's Heart FailureTest in Europe - Analyst Blog 5:40 p.m. April 11, 2013 - Zacks.com
BG Medicine Inc. CEO Discusses Q4 2012 Results - Earnings Call Transcript 10:51 a.m. March 13, 2013 - Seeking Alpha
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 8:00 a.m. Dec. 13, 2013 - PR Newswire
BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test 8:30 a.m. Dec. 10, 2013 - GlobeNewswire
Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure 8:30 a.m. Nov. 19, 2013 - GlobeNewswire
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer 8:30 a.m. Nov. 14, 2013 - GlobeNewswire
AXAS, POZN, ATRS and BGMD added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 6, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Third Quarter Financial Results 7:35 a.m. Nov. 6, 2013 - GlobeNewswire
SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test 7:30 a.m. Nov. 6, 2013 - GlobeNewswire
BG Medicine to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013 7:30 a.m. Oct. 30, 2013 - GlobeNewswire
Cardiac Biomarker ST2 Helps Assess Heart Failure Risk And Identify Heart Failure Patients Likely To Benefit From Exercise 7:30 a.m. Oct. 10, 2013 - BusinessWire
Cardiac Biomarker ST2 Proves Far Superior To Galectin-3 In A Head-to-Head Study 7:58 a.m. Sept. 30, 2013 - BusinessWire
BG Medicine Announces Preliminary Decision by CMS on Reconsideration of Reimbursement for BGM Galectin-3 Test 7:30 a.m. Sept. 30, 2013 - GlobeNewswire
BG Medicine, Inc. Welcomes Galectin-3 Clinical Research Data From the PROTECT Study Conducted at Massachusetts General Hospital Demonstrating Predictive Value of Adverse Outcomes in Heart Failure Patients 7:30 a.m. Sept. 23, 2013 - GlobeNewswire
BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the Heart Failure Society of America 7:30 a.m. Sept. 19, 2013 - GlobeNewswire
Flagship VentureLabs Launches Midori Renewables 12:18 p.m. Sept. 4, 2013 - PR Newswire
BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference 7:31 a.m. Sept. 4, 2013 - GlobeNewswire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 2:48 p.m. Aug. 28, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on BGMD, CORT, ELX and TTEK 7:51 a.m. Aug. 12, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Second Quarter Financial Results and Provides Second Half Outlook 6:45 a.m. Aug. 8, 2013 - GlobeNewswire
BG Medicine to Announce Second Quarter 2013 Financial Results and Host Conference Call on Thursday, August 8, 2013 7:30 a.m. Aug. 1, 2013 - GlobeNewswire
Flagship Ventures Kicks-off its VentureLabs(TM) Entrepreneurial Fellowship Program 8:15 a.m. June 20, 2013 - PR Newswire
BG Medicine Inc. falls 10% in premarket 7:58 a.m. Jan. 25, 2013 - Steve Gelsi
BG Medicine up 11% in premarket 7:57 a.m. Jan. 3, 2013 - Steve Gelsi
BG Medicine up by 16% in premarket 8:49 a.m. Dec. 14, 2012 - Steve Gelsi
BG Medicine rises 9% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi
BG Medicine names BioMerieux exec as CEO 9:12 a.m. Jan. 9, 2012 - Steve Gelsi
BG Medicine names Eric Bouvier as CEO 8:38 a.m. Jan. 9, 2012 - Steve Gelsi
IPO scorecard: Pacira, Epocrates up in aftermarket 1:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 1:31 p.m. April 26, 2011 - MarketWatch.com
HWAY and SulAmerica Join Forces, Shares Fall - Analyst Blog 6:30 p.m. Dec. 9, 2013 - Zacks.com
Omnicare Raises Dividend, Approves Share Repurchase - Analyst Blog 3:00 p.m. Dec. 9, 2013 - Zacks.com
Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape 9:25 a.m. Nov. 18, 2013 - Zacks.com
BG Medicine's CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:03 p.m. Nov. 6, 2013 - Seeking Alpha
Healthways Partnership Expands But Stock Down - Analyst Blog 1:50 p.m. Oct. 7, 2013 - Zacks.com
CareFirst Invests in Healthways Partnership - Analyst Blog 1:50 p.m. Oct. 4, 2013 - Zacks.com
NextGxDx and athenahealth Join Forces - Analyst Blog 5:10 p.m. Oct. 1, 2013 - Zacks.com
BG Medicine Says Prelim. Decision by CMS on Galectin-3 National limitation $30.24 6:33 a.m. Sept. 30, 2013 - benzinga.com
BG Medicine - Just Be Patient 3:02 a.m. Aug. 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 3:10 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
BG Medicine's CEO Discusses Q2 2013 Results - Earnings Call Transcript 12:35 p.m. Aug. 8, 2013 - Seeking Alpha
Don’t Take a Shot on That Small-Cap Biotech 5:48 a.m. June 11, 2013 - InvestorPlace.com
Emerging Biomarker Companies Redux: Positioned For Growth 2:31 p.m. May 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 3:18 p.m. May 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
BG Medicine's CEO Discusses Q1 2013 Results - Earnings Call Transcript 1:10 p.m. May 9, 2013 - Seeking Alpha
Zacks #1 Rank Additions for Thursday - Tale of the Tape 7:44 a.m. May 2, 2013 - Zacks.com
Zacks Rank #1 Addition for Friday - Tale of the Tape 7:44 a.m. April 19, 2013 - Zacks.com
Abbott Launches Automated Solution - Analyst Blog 5:00 p.m. April 18, 2013 - Zacks.com
Abbott's Heart FailureTest in Europe - Analyst Blog 5:40 p.m. April 11, 2013 - Zacks.com
BG Medicine Inc. CEO Discusses Q4 2012 Results - Earnings Call Transcript 10:51 a.m. March 13, 2013 - Seeking Alpha
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 8:00 a.m. Dec. 13, 2013 - PR Newswire
BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test 8:30 a.m. Dec. 10, 2013 - GlobeNewswire
Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure 8:30 a.m. Nov. 19, 2013 - GlobeNewswire
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer 8:30 a.m. Nov. 14, 2013 - GlobeNewswire
AXAS, POZN, ATRS and BGMD added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 6, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Third Quarter Financial Results 7:35 a.m. Nov. 6, 2013 - GlobeNewswire
SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test 7:30 a.m. Nov. 6, 2013 - GlobeNewswire
BG Medicine to Announce Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013 7:30 a.m. Oct. 30, 2013 - GlobeNewswire
Cardiac Biomarker ST2 Helps Assess Heart Failure Risk And Identify Heart Failure Patients Likely To Benefit From Exercise 7:30 a.m. Oct. 10, 2013 - BusinessWire
Cardiac Biomarker ST2 Proves Far Superior To Galectin-3 In A Head-to-Head Study 7:58 a.m. Sept. 30, 2013 - BusinessWire
BG Medicine Announces Preliminary Decision by CMS on Reconsideration of Reimbursement for BGM Galectin-3 Test 7:30 a.m. Sept. 30, 2013 - GlobeNewswire
BG Medicine, Inc. Welcomes Galectin-3 Clinical Research Data From the PROTECT Study Conducted at Massachusetts General Hospital Demonstrating Predictive Value of Adverse Outcomes in Heart Failure Patients 7:30 a.m. Sept. 23, 2013 - GlobeNewswire
BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 at the 17th Annual Scientific Meeting of the Heart Failure Society of America 7:30 a.m. Sept. 19, 2013 - GlobeNewswire
Flagship VentureLabs Launches Midori Renewables 12:18 p.m. Sept. 4, 2013 - PR Newswire
BG Medicine, Inc. to Present at the Baird 2013 Health Care Conference 7:31 a.m. Sept. 4, 2013 - GlobeNewswire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 2:48 p.m. Aug. 28, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on BGMD, CORT, ELX and TTEK 7:51 a.m. Aug. 12, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Second Quarter Financial Results and Provides Second Half Outlook 6:45 a.m. Aug. 8, 2013 - GlobeNewswire
BG Medicine to Announce Second Quarter 2013 Financial Results and Host Conference Call on Thursday, August 8, 2013 7:30 a.m. Aug. 1, 2013 - GlobeNewswire
Flagship Ventures Kicks-off its VentureLabs(TM) Entrepreneurial Fellowship Program 8:15 a.m. June 20, 2013 - PR Newswire
(0)
(0)